Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

This study has been terminated.
(Limited efficacy response observed at 1/3 enrollment at investigated dosage.)
Sponsor:
Information provided by (Responsible Party):
Dompé Farmaceutici S.p.A
ClinicalTrials.gov Identifier:
NCT01571895
First received: April 4, 2012
Last updated: June 25, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: No date given
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)